Home > Boards > US Listed > Biotechs > Regulus Therapeutics Inc. (RGLS)

You've never driven up/down Abilene Lubbock?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
slow_feet Member Profile
Member Level 
Followed By 28
Posts 2,801
Boards Moderated 2
Alias Born 09/13/00
160x600 placeholder
Regulus Therapeutics reports additional RGLS4326 data in polycystic kidney disease Seeking Alpha - 6/25/2021 8:38:18 AM
Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Co... PR Newswire (US) - 6/25/2021 7:05:00 AM
Regulus Therapeutics to Present Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD ... PR Newswire (US) - 6/21/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/16/2021 4:02:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:47:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:46:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:45:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:44:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:44:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:43:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:41:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 4:40:26 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/27/2021 4:04:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2021 4:08:47 PM
Regulus reports mixed results in early-stage trial for polycystic kidney disease Seeking Alpha - 5/21/2021 11:51:30 AM
Regulus Therapeutics Announces Incremental Update of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program PR Newswire (US) - 5/21/2021 8:07:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2021 7:14:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2021 7:13:25 PM
Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit PR Newswire (US) - 5/14/2021 4:07:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2021 6:04:31 AM
Regulus Therapeutics EPS beats by $0.01 Seeking Alpha - 5/13/2021 4:35:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2021 4:16:21 PM
Regulus Therapeutics Reports First Quarter 2021 Financial Results and Recent Updates PR Newswire (US) - 5/13/2021 4:07:00 PM
Regulus Therapeutics Announces Timing for First Quarter 2021 Financial Results Webcast and Conference Call PR Newswire (US) - 5/6/2021 5:15:00 PM
Regulus reports top-line data from early-stage RGLS4326 trial in polycystic kidney disease Seeking Alpha - 5/3/2021 8:24:44 AM
slow_feet Member Level  Sunday, 02/14/21 05:39:23 PM
Re: Porterhouse10 post# 317
Post # of 418 
You've never driven up/down Abilene Lubbock?


________________________________
There is a little black spot on the sun today
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences